(Q38154505)

29 August 2017

Energy metabolism and fertility: a balance preserved for female health (English)

1 reference

29 August 2017

Valeria Benedusi

2

0 references

Adriana Maggi

object named as

Adriana Maggi

series ordinal

4

0 references

author name string

Sara Della Torre

series ordinal

1

1 reference

PubMed ID

24146033

29 August 2017

Roberta Fontana

series ordinal

3

1 reference

29 August 2017

22 October 2013

1 reference

Nature Reviews Endocrinology

29 August 2017

1 reference

29 August 2017

10

1 reference

29 August 2017

1

1 reference

29 August 2017

13-23

1 reference

https://scigraph.springernature.com/pub.10.1038/nrendo.2013.203

29 August 2017

0 references

cites work

A varied pattern of change of the sex differential in survival in the G7 countries.

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Women's higher health risks in the obesogenic environment: a gender nutrition approach to metabolic dimorphism with predictive, preventive, and personalised medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

The metabolic syndrome in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Reproduction, fat metabolism, and life span: what is the connection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Vertebrate yolk proteins: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Vitellogenin synthesis by the fat body of the mosquito Aedes aegypti: evidence of transcriptional control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Extensive sequence conservation among insect, nematode, and vertebrate vitellogenins reveals ancient common ancestry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Regulation of Caenorhabditis elegans vitellogenesis by DAF-2/IIS through separable transcriptional and posttranscriptional mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Effect of insulin and 20-hydroxyecdysone in the fat body of the yellow fever mosquito, Aedes aegypti

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Ovarian Control of Vitellogenin Synthesis by the Fat Body in Aedes aegypti

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Metabolic fuel and clinical implications for female reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Biphasic effects of estrogen on apolipoprotein synthesis in human hepatoma cells: mechanism of antagonism by testosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Normal plasma lipoproteins and fertility in gene-targeted mice homozygous for a disruption in the gene encoding very low density lipoprotein receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Apolipophorin II/I, apolipoprotein B, vitellogenin, and microsomal triglyceride transfer protein genes are derived from a common ancestor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Knockout of the mouse apolipoprotein B gene results in embryonic lethality in homozygotes and protection against diet-induced hypercholesterolemia in heterozygotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Amino acid-dependent activation of liver estrogen receptor alpha integrates metabolic and reproductive functions via IGF-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Leptin indirectly regulates gonadotropin-releasing hormone neuronal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Ghrelin enhances appetite and increases food intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

The satiety hormone peptide YY as a regulator of appetite.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Insulin and leptin: dual adiposity signals to the brain for the regulation of food intake and body weight.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Tetradian oscillation of estrogen receptor α is necessary to prevent liver lipid deposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Bioidentical hormones for maturing women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

The Gestational Pattern of Estradiol, Testosterone and Progesterone Secretion in Selected Strains of Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Estrogen modulates abdominal adiposity and protects female mice from obesity and impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Ovarian hormone status and abdominal visceral adipose tissue metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Increased adipose tissue in male and female estrogen receptor-alpha knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Effects of selective estrogen receptor agonists on food intake and body weight gain in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Activation of ERα is necessary for estradiol's anorexigenic effect in female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Generation and reproductive phenotypes of mice lacking estrogen receptor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Estradiol enhances cholecystokinin-dependent lipid-induced satiation and activates estrogen receptor-alpha-expressing cells in the nucleus tractus solitarius of ovariectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Effects of intracerebroventricular ghrelin on food intake and Fos expression in the arcuate nucleus of the hypothalamus in female rats vary with estrous cycle phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Distinct hypothalamic neurons mediate estrogenic effects on energy homeostasis and reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Functional requirement of AgRP and NPY neurons in ovarian cycle-dependent regulation of food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Role of cocaine- and amphetamine-regulated transcript in estradiol-mediated neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Direct action of estradiol on gonadotropin-releasing hormone-1 neuronal activity via a transcription-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Gonadal hormones determine sensitivity to central leptin and insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Kisspeptin signaling in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Increased visceral fat and decreased energy expenditure during the menopausal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Key lipogenic gene expression can be decreased by estrogen in human adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Long-term administration of estradiol decreases expression of hepatic lipogenic genes and improves insulin sensitivity in ob/ob mice: a possible mechanism is through direct regulation of signal transducer and activator of transcription 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Metabolic impact of estrogen signalling through ERalpha and ERbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Estrogen receptor activation reduces lipid synthesis in pancreatic islets and prevents β cell failure in rodent models of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Pancreatic insulin content regulation by the estrogen receptor ER alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Extranuclear estrogen receptor-alpha stimulates NeuroD1 binding to the insulin promoter and favors insulin synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

The pancreatic beta-cell as a target of estrogens and xenoestrogens: Implications for blood glucose homeostasis and diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Dose- and time-dependent effects of 17beta-oestradiol on insulin sensitivity in insulin-dependent tissues of rat: implications of IRS-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Pregnancy and laboratory studies: a reference table for clinicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

A new approach to menopausal therapy: the tissue selective estrogen complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Differential expression of factors involved in fat metabolism with age and the menopause transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Obesity is associated with macrophage accumulation in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Inflammation and metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Influence of age and menopause on serum lipids and lipoproteins in healthy women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Estrogen action in neuroprotection and brain inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Chronic 17beta-estradiol treatment improves skeletal muscle insulin signaling pathway components in insulin resistance associated with aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Insulin resistance: a metabolic pathway to chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Apolipoprotein synthesis in nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Molecular mechanisms involved in NAFLD progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Genes and nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Effects of ovariectomy on PPAR alpha, SREBP-1c, and SCD-1 gene expression in the rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Hepatic VLDL-TG production and MTP gene expression are decreased in ovariectomized rats: effects of exercise training.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Polycystic Ovary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Diagnostic criteria for polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Serum luteinizing hormone levels are markedly increased and significantly correlated with Delta 4-androstenedione levels in lean women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Metformin has direct effects on human ovarian steroidogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Turner syndrome: the case of the missing sex chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Cardiovascular phenotype in Turner syndrome--integrating cardiology, genetics, and endocrinology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner's syndrome. The impact of sex hormone replacement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Monosomy for the X-chromosome is associated with an atherogenic lipid profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Cardiovascular risk factors in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Liver dysfunction in Turner's syndrome: prevalence, natural history and effect of exogenous oestrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Elevated liver enzymes in Turner syndrome during a 5-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Vascular involvement of the liver in Turner's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Hormone replacement therapy may improve hepatic function in women with Turner's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Adipokine dysregulation in turner syndrome: comparison of circulating interleukin-6 and leptin concentrations with measures of adiposity and C-reactive protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Impaired insulin secretion in the Turner metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Insulin resistance: an early metabolic defect of Turner's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Reduced pericellular sensitivity to IGF-I in fibroblasts from girls with Turner syndrome: a mechanism to impair clinical responses to GH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Quantitative liver functions in Turner syndrome with and without hormone replacement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Disrupted circadian rhythms in a mouse model of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Unexpected features of Drosophila circadian behavioural rhythms under natural conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Location, location, location: important for jet-lagged circadian loops

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Circadian rhythms govern cardiac repolarization and arrhythmogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

The conundrum of estrogen receptor oscillatory activity in the search for an appropriate hormone replacement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

An innovative method to classify SERMs based on the dynamics of estrogen receptor transcriptional activity in living animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Synthesis of vitellogenin in cultures of male and female frog liver regulated by estradiol treatment in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Induction of three vitellogenins by 17beta-estradiol with concurrent inhibition of the growth hormone-insulin-like growth factor 1 axis in a euryhaline teleost, the tilapia (Oreochromis mossambicus).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Association of serum protein levels with egg productivity in Taiwan red-feathered country chickens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Growth hormone and insulin-like growth factor-I in inducing vitellogenin synthesis by frog hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Effects of arginine on pancreatic hormones and hepatic metabolism in rainbow trout

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Epidemiological, endocrine and metabolic features in Turner syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Morbidity in Turner Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Recommendations for the Diagnosis and Management of Turner Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

The Distribution of Cells Containing Estrogen Receptor- (ER ) and ER Messenger Ribonucleic Acid in the Preoptic Area and Hypothalamus of the Sheep: Comparison of Males and Females

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Obesity as a medical problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Estrogen receptor null mice: what have we learned and where will they lead us?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Concentration of unconjugated estrone and estradiol in peripheral plasma in nonpregnant women throughout the menstrual cycle, castrate and postmenopausal women and in men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Chronological Changes in Sex Steroid, Gonadotropin and Prolactin Secretion in Aging Female Rats Displaying Different Reproductive States1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Ablation of estrogen receptor alpha (ERalpha) prevents upregulation of POMC by leptin and insulin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Estrogen directly respresses gonadotropin-releasing hormone (GnRH) gene expression in estrogen receptor-alpha (ERalpha)- and ERbeta-expressing GT1-7 GnRH neurons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

The distribution of cells containing estrogen receptor-alpha (ERalpha) and ERbeta messenger ribonucleic acid in the preoptic area and hypothalamus of the sheep: comparison of males and females

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Association of polymorphisms in the estrogen receptor alpha gene with body fat distribution

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Some effects of oral contraceptives on carbohydrate metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of added progestin.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Relative contribution of aging and menopause to changes in lean and fat mass in segmental regions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Sex- and menopause-associated changes in body-fat distribution

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Differences in Low Density Lipoprotein Subfractions and Apolipoproteins in Premenopausal and Postmenopausal Women*

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Excess visceral and hepatic adipose tissue in Turner syndrome determined by magnetic resonance imaging: estrogen deficiency associated with hepatic adipose content

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Alteration of cardiovascular risk parameters in women with polycystic ovary syndrome who were prescribed to ethinyl estradiol-cyproterone acetate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Variations of bloodpressure in hypertensives during sleep

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.203

Weight gain at the time of menopause

31 March 2020

1 reference

12 December 2020

Advances in diabetes for the millennium: diabetes in women

1 reference

12 December 2020

The low density lipoprotein receptor in Xenopus laevis. I. Five domains that resemble the human receptor

1 reference

12 December 2020

Recommendations for the diagnosis and management of Turner syndrome

1 reference

12 December 2020

Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.

1 reference

12 December 2020

Effects of gender and menopausal status on plasma lipoprotein subspecies and particle sizes.

1 reference

12 December 2020

Sarcopenia and muscle function during menopause and hormone-replacement therapy

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2013.203

1 reference

29 August 2017

1 reference

PubMed ID

24146033